Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Gilead Sciences to Promote Low-Cost HIV Medicine in Developing World
Aug. 6, 2012
Gilead Sciences said it plans to partner with Mylan, Ranbaxy Laboratories and Strides Arcolab to promote access to high-quality, low-cost generic versions of Gilead’s HIV medicine emtricitabine in developing countries.
The Wall Street Journal
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing